HIV Prevention and Substance Use Treatment for People Who Use Drugs
This study is testing a new approach called LINKED to help people who inject drugs prevent HIV and get treatment for substance use. LINKED uses social networks to share information and encourage the use of PrEP (pre-exposure prophylaxis, a medicine to prevent HIV) and MOUD (medications for opioid use disorder). Another group will receive a group intervention focusing on HIV and overdose risks. The study aims to see how many participants start using PrEP and MOUD at 6 and 12 months. You might be able to join if you are 18 or older, live in the Los Angeles area, can complete surveys in English, and have injected drugs in the past 3 months. The study is currently unclear about its recruitment status and plans to enroll 398 people.
- Study design
- This is an interventional study that will compare the LINKED social network intervention to a group intervention. It plans to enroll 398 participants.
- What's involved
- Participants will complete surveys and attend group sessions. The study will follow up with participants at 6 and 12 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 6 and 12 months after the intervention to assess PrEP and MOUD uptake.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs
At a glance
Conditions
Where it's being run
3 sites across 3 statesStudy leadership
- Suzan Walters, PhD · PRINCIPAL_INVESTIGATOR · NYU Langone Health
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Percentage of Participants with PrEP UptakeMonth 6
Measured via filled PrEP prescription.
- Percentage of Participants with PrEP UptakeMonth 12
Measured via filled PrEP prescription.
- Percentage of Participants with MOUD UptakeMonth 6
Measured via filled MOUD prescription or buprenorphine, methadone, or naltrexone enrollment.
- Percentage of Participants with MOUD UptakeMonth 12
Measured via filled MOUD prescription or buprenorphine, methadone, or naltrexone enrollment.
- Percentage of Participants with PrEP AdherenceMonth 6
Measured via urine immunoassays to test for oral PrEP.
- Percentage of Participants with PrEP AdherenceMonth 12
Measured via urine immunoassays to test for oral PrEP.
- Percentage of Participants with MOUD AdherenceMonth 6
Measured via urinalysis to test for metabolites for MOUD.
- Percentage of Participants with MOUD AdherenceMonth 12
Measured via urinalysis to test for metabolites for MOUD.